Intrum's stock surged 11% on Monday after the company unveiled a fully underwritten SEK 7.5 billion capital increase and UBS upgraded the shares to Buy. The Swiss bank characterised the financing as a pivotal move that reduces refinancing tail risk and accelerates the company's deleveraging trajectory.
UBS analysts quantified the immediate balance-sheet impact. On a pro forma basis, group net debt to EBITDA is estimated to fall to roughly 3.8x from 4.6x, and Servicing leverage is said to drop to about 4.1x from 5.8x. Those shifts in leverage underpin UBS's view that Intrum will enjoy improved access to funding and a more predictable path to normalised borrowing costs.
The bank also estimated at least SEK 400 million in annual interest savings as a result of the reduced debt burden. UBS noted there could be upside to that estimate depending on whether the proceeds are used to retire higher-cost borrowings rather than merely paying down the revolving credit facility.
UBS framed the capital raise as a material inflection for shareholders. "The transaction materially reduces refinancing tail risk, accelerates deleveraging and restores a more credible path toward normalised funding access and costs," the analysts wrote. They described the move as the first significant step-change event since the company's Chapter 11 process that alters the probability-weighted outcome for investors.
Despite the favourable balance-sheet implications, dilution for existing shareholders is substantial. UBS flagged dilution of more than 75% based on the current share price, stressing that the heavy dilution is the price of removing the elevated risk premium that had weighed on the stock.
On operational forecasts, UBS said it made limited adjustments. The bank acknowledged somewhat faster cost reductions and higher planned investment activity versus prior assumptions, which was partly offset by weaker organic growth in the Servicing business. Management has indicated that the additional capital gives the company flexibility to step up cost actions or selectively pursue investments.
UBS also outlined a clearer medium-term leverage pathway: it now sees a route for Intrum to reach 3x Servicing leverage by 2028 and 3x group leverage by 2030. The combination of immediate deleveraging and anticipated interest savings underpins UBS's more constructive stance, which prompted the upgrade to Buy.
The market reaction was pronounced, with the stock jumping double digits on the news. The transaction, fully underwritten at SEK 7.5 billion, will be watched closely for how management allocates proceeds between refinancing higher-cost debt and other uses, and for the execution of the cost and investment plans that UBS says have been modestly upgraded in its models.